OSIR
Osiris Therapeutics, Inc. Common Stock
OSIR
OSIR
Delisted
OSIR was delisted on the 16th of April, 2019.
67 hedge funds and large institutions have $126M invested in Osiris Therapeutics, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
19% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 26
52% less call options, than puts
Call options by funds: $3.34M | Put options by funds: $6.9M
Holders
67
Holding in Top 10
1
Calls
$3.34M
Puts
$6.9M
Top Buyers
| 1 | +$15.7M | |
| 2 | +$1.36M | |
| 3 | +$743K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$516K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$435K |
Top Sellers
| 1 | -$5.19M | |
| 2 | -$1.25M | |
| 3 | -$454K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$342K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$211K |